Precision Building Blocks for Global Pharmaceutical Innovation
At Medkem, we recognize that the quality of an Active Pharmaceutical Ingredient (API) is fundamentally defined by the quality of its intermediates. As a specialized CDMO for API Intermediates, we provide the chemical expertise and high-capacity infrastructure required to produce the complex building blocks that power today’s most advanced therapies.
Our Expertise in Intermediate Chemistry
We specialize in bridging the gap between raw materials and sophisticated drug substances. Our chemical development teams are experts in:
- Complex Multi-Step Synthesis:Handling 10+ step synthesis with a focus on maintaining high isomeric and chiral purity.
- Advanced Reactions:Expertise in high-pressure reactions, cryogenic chemistry, and specialized catalysts that many standard manufacturers cannot accommodate.
- Niche Intermediates:Developing and scaling up advanced intermediates for oncology, cardiovascular, and CNS therapeutic areas.
Integrated Development & Scaling
Medkem’s CDMO model for intermediates is built to support you from the first laboratory pilot to multi-ton commercial supply:
- Route Scouting & Optimization:Our R&D teams evaluate existing chemical routes to identify more cost-effective, environmentally friendly, and safer “green chemistry” alternatives.
- Pilot Plant to Commercial Scale:We ensure a seamless transition from gram-scale process validation to high-volume production in our state-of-the-art glass-lined and stainless steel reactors.
- Impurity Profiling:We provide rigorous analytical data to ensure that all intermediates meet the stringent “Regulatory Starting Material” (RSM) standards required for final API filings.
Why Medkem for Intermediates?
- Supply Chain Resilience
In an era of global disruption, Medkem offers a stable and reliable manufacturing base. We manage our own raw material sourcing to ensure that your intermediate production is never delayed by upstream shortages.
- Cost-Leadership through Process Engineering
We don’t just manufacture; we optimize. By refining reaction conditions and solvent recovery processes, we help our partners reduce the “Total Cost of Goods” (COGS), making your final API more competitive in the global market.
- Uncompromising Quality & Compliance
While intermediates often have different regulatory requirements than final APIs, Medkem maintains a “Quality First” culture. We follow stringent internal quality management systems that mirror GMP standards, providing you with the documentation and traceability needed for seamless inclusion in your Drug Master Files (DMF).
- Intellectual Property Protection
Your proprietary chemical routes are your most valuable assets. Medkem provides a secure environment with robust non-disclosure frameworks and isolated production blocks to ensure your IP is protected throughout the manufacturing lifecycle.
Power Your API Pipeline with Medkem
Strategic sourcing starts with superior intermediates. Partner with Medkem to ensure your drug substance has the strongest possible foundation.